Multiple sclerosis (MS) is the most common chronic inflammatory neurologic disorder diagnosed in young adults and, due to its chronic course, is responsible for a substantial economic burden. MS is considered to be a multifactorial disease in which both genetic and environmental factors intervene. The well-established human leukocyte antigen (HLA) association does not completely explain the genetic impact on disease susceptibility. However, identification and validation of non-HLA-genes conferring susceptibility to MS has proven to be difficult probably because of the small individual contribution of each of these genes. Recently, associations with two single nucleotide polymorphisms (SNPs) in the IL2RA gene (rs12722489, rs2104286) and one SNP in the IL7RA gene (rs6897932) have been reported by several groups. These three SNPs were genotyped in a French and a German population of MS patients using the hME assay by the matrix-assisted laser desorption/ionization time of flight technology (Sequenom, San Diego, CA, USA). We show that these SNPs do contribute to the risk of MS in these two unrelated European MS patient populations with odds ratios varying from 1.1 to 1.5. The discovery and validation of new genetic risk factors in independent populations may help toward the understanding of MS pathogenesis by providing valuable information on biological pathways to be investigated.
Introduction
Multiple sclerosis (MS)-the most common cause of chronic neurologic disability beginning in early to middle adult life-is considered to be a multifactorial disease involving both genetic and environmental factors. Evidence of genetic contribution to MS susceptibility arose from familial aggregation, twin studies and high incidence in populations of northern European origin, when compared with African and Asian groups. 1 The prevalence pattern may be explained, at least in part, by migrations of northern European groups and their descendants which strengthens the hypothesis of genetic factors contributing to MS. 2 Epidemiological studies performed in twins and siblings clearly indicate the impact of genetic factors. 3, 4 In addition, the geographical distribution of MS and studies of migrants also suggest a considerable contribution of environmental factors that may not be evenly distributed over the world.
Current evidence indicates that there is not only one gene conferring susceptibility, but rather a number of genes-each contributing only a small amount. 5 A large number of studies performed so far confirmed HLA-DRB1 on chromosome 6p21 to represent a major risk factor for MS in all populations tested. 6 However, it does not fully explain the genetic basis of the disease. 7, 8 Other loci outside the human leukocyte antigen (HLA) region were suspected by the results of several candidate genes or genome-wide approaches, but could not be validated in other samples-until recently. Variations in the interleukin-2 receptor-a gene (IL2RA) and the interleukin-7 receptor-a chain (IL7RA) were demonstrated to confer a risk for MS in candidate gene approaches and a whole genome screen. [9] [10] [11] The association of MS with IL7RA was originally reported in a candidate gene approach by Zhang et al. 12 2 years ago, and is now replicated on large additional samples. [9] [10] [11] Interestingly, linkage to chromosome 5p13, precisely where IL7RA is located, was also reported in a Canadian MS cohort with a maximum logarithm (base 10) of odds score of 4.24 13 and supported later by others.
14 With respect to IL2RA, genome-wide linkage analysis has shown potential linkage on chromosome 10p15, which contains the IL2RA gene. 15 Subsequently, a candidate approach on this gene first suggested an association between MS and IL2RA. 16 This result was strongly supported by the whole genome approach on extremely large samples.
11
This study reports the results obtained in two independent European MS samples (French and German) by genotyping the three single nucleotide polymorphisms (SNPs) showing the strongest association with MS in the study of the International Multiple Sclerosis Genetics Consortium. 11 Two SNPs are within the IL2RA gene (rs12722489, rs2104286) and one in the IL7RA gene (rs6897932).
Results
The three SNPs (rs12722489, rs2104286 and rs6897932) were typed in the German sample, consisting of 206 MS patients and 605 age and sex-matched controls, and in the French sample, consisting of 540 MS trios. Basic demographics of both samples are given in Table 1 . A statistical comparison showed significant difference between the samples for age at time of analysis, disease course and Expanded Disability Status Scale (EDSS). However, these differences do not alter the overall genetic findings discussed below.
Risk allele frequency (RAF) for the three SNPs, given in Table 2 , were estimated from the German control sample and from the French untransmitted allele sample, respectively. No significant difference was found between our two populations, and the RAFs are very similar to that of the original report. 11 We first estimated the expected power of our two samples, under two scenarios (see Materials and methods section) represented by the allele frequencies (0.75 for the two first SNPs and 0.85 for the third one) and the corresponding odds ratio (1.2 and 1.25 respectively) given in the original report. In both scenarios, the expected power for the French trio sample and the German sample was 56 and 38%, respectively. This clearly demonstrates the interest in the joint analysis of samples.
Since our aim is to replicate the signals found in other populations, all the P-values reported here are based on a one-sided test. In the trios, 213 transmissions were informative for rs12722489, 355 were informative for rs2104286 and 389 were informative for rs6897932, respectively. The SNP rs2104286 within the IL2RA gene demonstrated a significant association in the French MS trios and the German sample-whether analysed separately or combined in both samples ( Table 2) . The SNP rs12722489, also located within the IL2RA gene, shows significant association in the German sample and a positive trend in the French trios (Table 2) . Linkage disequilibrium between these two SNPs is strong (D 0 ¼ 1 in the German cases, German controls, and French case chromosomes, with D 0 estimated at 0.989 in the French control chromosomes), but far from perfect (r 2 ¼ 0.500, 0.552, 0.555 and 0.417, for the above-mentioned samples, respectively). The SNP rs6897932 located within the IL7RA gene exhibits a significant association in the French trios and a positive trend in the German sample. Combining the results of both samples a significant Pvalue is obtained (Table 2) .
Discussion
The identification of non-HLA genes conferring susceptibility for MS is difficult. Linkage analysis in nuclear families failed to identify additional loci with genomewide significance, 8, 17 but highlighted the IL2R and IL7R regions [13] [14] [15] and the involvement of these two genes were suggested by candidate gene approaches. 12, 16 Recent work 9-11 on extremely large samples rendered IL2RA and IL7RA highly attractive and motivated further investigations. The risks associated to the SNPs of IL2RA and IL7RA however are modest at best (odds ratios between 1.1 and 1.5), so that only replications in a large number of different samples will make their involvement in MS susceptibility convincing.
We confirm here the positive association with the same risk alleles within the IL2RA and the IL7RA genes in two independent European samples. The odds ratios are consistent with those previously published. [9] [10] [11] The two SNPs typed in the IL2RA gene are in strong, but not perfect, linkage disequilibrium, which could explain the observed difference in P-values and odds ratios obtained. Therefore, our findings convincingly corroborate the recently published results.
In the meantime, another independent replication on a Canadian sample 18 published similar results. In addition, association of IL2RA with MS susceptibility was also recently concluded by Matesanz et al. 16 with other SNPs located within the IL2RA gene. Further studies on this gene are needed to make a link between those different signals. 19 In addition, it will be very important to take advantage of both the linkage and association information for a better understanding and a refined modelization of the effects of both the IL2RA and IL7RA genes. 20, 21 Together with the well-known HLA association these results fit very well the assumption that MS is an autoimmune disease caused by lymphocytes and monocytes infiltrating the central nervous system. 22 Both cytokines are of central importance in promoting the growth and differentiation of T and B cells. IL-2 is an essential T-cell growth factor required for division of antigen-activated T cells. Activation of T cells induces the synthesis of IL2RA and the formation of the high-affinity IL-2 receptor, allowing the cell to respond to very low concentrations of IL-2. IL-7 is important for memory T cells and the development of g/D T cells, which are present in inflammatory lesions of MS patients. 23, 24 The a-chain of its receptor expresses differently according to the IL7RA genotypes. 25 Interestingly, the likely causal SNP in the IL7RA gene has been shown to be responsible for increased exon skipping, which results in the production of more soluble IL-7 receptor than those of the membrane-bound isoform. 10 Only marginal effect of these genes has been tested. They may interact with other genes. Even if, as underlined in the elegant editorial of Peltonen, 26 these two genes do not provide clues for unsuspected pathways, focusing on genes which are biologically interacting with IL2RA and IL7RA will be the next step. As stated by Marrosu, 27 'the implication of interleukins in susceptibility to MS might lead to new avenues of investigation'.
Taking into account the complexity of MS including the participation of other immune cells, for example monocytes, other cytokines, adhesion molecules, growth factors and neurodegenerative processes, there is a high probability that additional pathways are involved in pathogenesis. Unravelling the MS mystery is just beginning.
Materials and methods

Patients and controls
Demographic features of patients and controls are given in Table 1 . All patients were diagnosed as MS according to the criteria of Poser et al. 28 or McDonald et al. 29 In total, 206 German MS patients were recruited at the Max Planck Institute of Psychiatry, Munich and at the Department of Neurology, University of Wü rzburg. In total, 605 healthy controls matched for ethnicity, age and sex were recruited at the Max Planck Institute of Table 2 Association of IL2RA and IL7RA with MS in two independent European populations Abbreviations: IL2RA, interleukin-2 receptor-a gene; IL7RA, interleukin-7 receptor-a chain; RAF, risk allele frequency.
P-values, odds ratios and 95 % confidence intervals were calculated separately for each population and after combining both samples. Both P-values and 95% confidence intervals are one-sided, that is the 95% lower bound for the odds ratio is given.
IL2RA and IL7RA as risk factors for MS F Weber et al Psychiatry, Munich. Controls were selected randomly from a Munich-based community sample and screened for the absence of anxiety and affective disorders using the Composite International Diagnostic-Screener. 30 History of somatic and neurological disorders of the subjects and their first-degree relatives was recorded using a selfreport questionnaire. Only individuals negative in the screening questions for psychiatric disorders and with a negative personal and family history for MS were included. All participants underwent a brief physical examination, including blood analysis and drug monitoring. In total, 540 MS trios (case and their parents) were provided by the French network dans le cadre du réseau français d'étude génétique de la SEP (REFGEN-SEP). Cases were reviewed by a board-certified neurologist and diagnosed with criteria referred to above. Only cases with a defined diagnosis were included. Patients originated from all over France even if most of the samplings were performed in three centres (Paris, Rennes and Toulouse). Parents were asked about their medical history before the blood puncture was performed. The study was approved by the ethics committee of the Ludwig Maximilian University (Munich, Germany), the Julius Maximilians University (Wü rzburg, Germany) and the Groupe Hospitalier Pitié-Salpêtrière (Paris, France) respectively, and performed according to European Community, German and French Bioethics Laws. Written informed consent was obtained from all subjects according to a protocol validated by ethics committees.
Sample preparation and statistical analysis DNA was extracted from peripheral blood leucocytes and concentration adjusted using standard protocols. SNP genotyping was performed with the hME assay by the matrix-assisted laser desorption/ionization time of flight technology (Sequenom, San Diego, CA, USA) as described. 31 All three SNPs were genotyped together with SNPs of a completely different project in high multiplexed iPlexes. Both IL2RA SNPs (rs12722489, rs2104286) were part of an iPlex containing 28 SNPs. The IL7RA SNP rs6897932 was in an iPlex comprising 10 SNPs. All subjects' DNAs were typed on eight different 384-well plates. The mean call rates (standard) over all eight plates per SNP were 99.8% (0.3%) for rs12722489, 99.3% (0.9%) for rs2104286 and 98.8% (1.8%) for rs6897932. All three SNPs were in Hardy-Weinberg equilibrium (no P-value below 0.05) on each single plate. PCR and extension primer sequences may be obtained upon request.
Demographic data were tested for differences using w 2 -analysis of contingency tables. Allele frequencies were estimated from the German control sample and from the French untransmitted allele sample.
Statistical analysis was performed using the UN-PHASED Software v 3.0.10. which allows joint analysis of data from trios and unrelated individuals. 32 As in the original report, 11 we used the multiplicative (log additive) model for risk. Since our aim is to replicate the signals found in other populations, all the P-values reported are based on a one-sided test. Power for a onesided test with a ¼ 0.05 was calculated with Genetic Power Calculator (http://pngu.mgh.harvard.edu/~pur-cell/gpc/) under two scenarios, assuming first an allele frequency of 0.75 for the associated allele and a relative risk of 1.2, second with an allele frequency of 0.85 and a relative risk of 1.25.
